0001437749-26-009391
SEC filingParkerVision, Inc. (PRKR) reported no licensing revenue for FY 2025, consistent with FY 2024, as the company focuses on patent enforcement litigation rather than commercialization. Net loss improved to $7.4 million from $14.5 million in 2024, driven by a $570K positive change in fair value of contingent payment obligations versus a $9.6 million negative change prior year, partially offset by higher SG&A expenses of $7.6 million versus $4.3 million. EPS improved to ($0.06) from ($0.16). Cash and equivalents stood at $4.4 million at year-end, down $0.6 million YoY after $5.1 million used in operations, offset by $4.6 million from financing. Total assets were $5.4 million, with shareholders' deficit of $45.1 million due to $50.5 million liabilities, primarily $46.0 million in contingent payment obligations tied to future patent proceeds. The auditor raised substantial doubt about going concern due to losses and liquidity risks. Ongoing litigation against Qualcomm, Realtek, MediaTek, and others remains central, with trials scheduled into 2026. Future performance hinges on litigation outcomes for revenue realization.
ParkerVision reported a net loss of $7.426 million for FY 2025, an improvement from $14.472 million in 2024, primarily due to a favorable $570K change in fair value of contingent payment obligations compared to a $9.639 million unfavorable change prior year. Licensing revenue remained at $0 for both years. SG&A expenses rose to $7.606 million from $4.262 million, driven by $3.3 million in share-based compensation. Gross margin was negative at ($199K) versus ($229K). Basic and diluted EPS improved to ($0.06) from ($0.16), with weighted average shares at 121,319 thousand versus 92,150 thousand. Total assets were $5.359 million, down from $5.879 million. The company operates as a single segment focused on RF technology licensing via patent enforcement.
No licensing revenue was recognized in 2025 or 2024, as proceeds from patent enforcement actions are unpredictable in timing and amount. The business model relies on litigation settlements and licensing from ongoing suits against Qualcomm, Realtek, MediaTek, LG, TCL, and others in U.S. district courts. Five existing licensees stem from prior enforcement. Cost of sales, amortization of patents linked to licensing, was $199K in 2025 versus $229K in 2024. No geographic breakdown disclosed.
Gross margin remained negative due to zero revenue and patent amortization costs. Operating expenses totaled $7.606 million, up significantly YoY due to elevated share-based compensation ($3.3M vs $0.4M). No operating margin calculable with zero revenue. Net loss before tax was $7.426 million, with zero tax provision due to valuation allowance on deferred tax assets. Accumulated deficit reached $455.6 million.
Net cash used in operating activities was $5.143 million, worsening from $3.216 million, reflecting net loss adjusted for non-cash items like $3.280 million share-based compensation. Investing used $61K on patents/equipment. Financing provided $4.646 million from stock/warrant issuances ($4.358M) and exercises ($427K), minus $139K debt payments. Cash ended at $4.360 million. Current liabilities $2.409 million include $1.225 million convertible notes current. Long-term liabilities $48.054 million dominated by $39.650 million secured and $6.439 million unsecured contingent obligations. Shareholders' deficit $45.104 million.
Management emphasizes patent enforcement as primary focus, with nine actions pending, including expedited CAFC appeal vs Qualcomm and trials vs Realtek (April 2026) and MediaTek. Substantial doubt on going concern noted due to losses, negative cash flows, and $455.6M accumulated deficit. Liquidity depends on litigation proceeds exceeding contingents, cost control, note conversions, or new financing. Auditor highlights fair value estimates of contingents as critical audit matter. No specific guidance on revenue timing.